Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 3
2004 2
2005 1
2006 4
2007 2
2008 2
2009 7
2010 2
2011 5
2012 3
2013 4
2014 4
2015 7
2016 5
2017 3
2018 1
2020 4
2021 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Results by year

Filters applied: . Clear all
Page 1
The significance of Treg cells in defective tumor immunity.
Kosmaczewska A, Ciszak L, Potoczek S, Frydecka I. Kosmaczewska A, et al. Among authors: frydecka i. Arch Immunol Ther Exp (Warsz). 2008 May-Jun;56(3):181-91. doi: 10.1007/s00005-008-0018-1. Epub 2008 May 30. Arch Immunol Ther Exp (Warsz). 2008. PMID: 18512029 Free article. Review.
Cytotoxic T-lymphocyte associated antigen 4 gene polymorphisms and autoimmune thyroid disease: a meta-analysis.
Kavvoura FK, Akamizu T, Awata T, Ban Y, Chistiakov DA, Frydecka I, Ghaderi A, Gough SC, Hiromatsu Y, Ploski R, Wang PW, Ban Y, Bednarczuk T, Chistiakova EI, Chojm M, Heward JM, Hiratani H, Juo SH, Karabon L, Katayama S, Kurihara S, Liu RT, Miyake I, Omrani GH, Pawlak E, Taniyama M, Tozaki T, Ioannidis JP. Kavvoura FK, et al. Among authors: frydecka i. J Clin Endocrinol Metab. 2007 Aug;92(8):3162-70. doi: 10.1210/jc.2007-0147. Epub 2007 May 15. J Clin Endocrinol Metab. 2007. PMID: 17504905 Review.
The soluble CTLA-4 receptor: a new marker in autoimmune diseases.
Pawlak E, Kochanowska IE, Frydecka I, Kiełbiński M, Potoczek S, Bilińska M. Pawlak E, et al. Among authors: frydecka i. Arch Immunol Ther Exp (Warsz). 2005 Jul-Aug;53(4):336-41. Arch Immunol Ther Exp (Warsz). 2005. PMID: 16088318 Review.
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Sava GP, Speedy HE, Di Bernardo MC, Deaglio S, Karabon L, Frydecka I, Woszczyk D, Rossi D, Gaidano G, Mansouri L, Smedby KE, Juliusson G, Rosenquist R, Catovsky D, Houlston RS. Sava GP, et al. Among authors: frydecka i. Br J Haematol. 2013 Jul;162(2):221-8. doi: 10.1111/bjh.12366. Epub 2013 May 14. Br J Haematol. 2013. PMID: 23668599 Free article.
Inappropriate Expression of PD-1 and CTLA-4 Checkpoints in Myeloma Patients Is More Pronounced at Diagnosis: Implications for Time to Progression and Response to Therapeutic Checkpoint Inhibitors.
Kulikowska de Nałęcz A, Ciszak L, Usnarska-Zubkiewicz L, Pawlak E, Frydecka I, Szmyrka M, Kosmaczewska A. Kulikowska de Nałęcz A, et al. Among authors: frydecka i. Int J Mol Sci. 2023 Mar 17;24(6):5730. doi: 10.3390/ijms24065730. Int J Mol Sci. 2023. PMID: 36982802 Free PMC article.
59 results